Join us as we share the latest on respiratory variant trends, and as we discuss how health systems and other organizations can leverage learnings from these past two years as we look beyond the pandemic and towards enabling healthier outcomes for entire communities now and into the future.
Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by our proprietary Exome+® assay, Helix offers health systems a scalable solution that enables the discovery of medically relevant, potentially life-saving, genetic Information. Prior to Helix, James was a faculty member at Duke University where he focused on translational genomics and machine learning methodologies for EMRs. James has explored research topics in population genetics, Mendelian genomics, and computational psychiatry.
Dr. Scarpino is an Affiliate Assistant Professor in the Department of Physics and holds appointments in the Network Science Institute, Institute for Experiential AI, Global Resilience Institute, and Roux Institute at Northeastern University. Scarpino has over 10 years of experience translating research into decision support and data science tools across diverse sectors from public health and clinical medicine to real estate and energy. From 2017-2020, he was Chief Strategy Officer and head of data science at the tech startup Dharma Platform. Scarpino has nearly 100 publications in academic journals and books. His commentaries on science and technology have appeared in publications such as: Nature, Science, PNAS, and Nature Physics. His research has been covered by the New York Times, Wired, NPR, VICE News, and other venues. He was made a Fellow of the ISI Foundation in 2017 and an External Faculty member of the Santa Fe Institute in 2020.